• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density.

作者信息

Stepan J, Ish-Shalom S, Hawkins F, Marín F, Farrerons J, Kapetanos G

出版信息

Osteoporos Int. 2010 Jun;21(6):1037-8; author reply 1039-40. doi: 10.1007/s00198-009-1157-x. Epub 2010 Jan 27.

DOI:10.1007/s00198-009-1157-x
PMID:20107976
Abstract
摘要

相似文献

1
The effects of strontium ranelate on biochemical markers of bone turnover and their relationship with bone mineral density.雷奈酸锶对骨转换生化标志物的影响及其与骨密度的关系。
Osteoporos Int. 2010 Jun;21(6):1037-8; author reply 1039-40. doi: 10.1007/s00198-009-1157-x. Epub 2010 Jan 27.
2
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.在使用雷奈酸锶治疗 3 年后，骨代谢生化标志物 3 个月变化与骨密度变化和骨折发生率的关系。
Osteoporos Int. 2010 Jun;21(6):1031-6. doi: 10.1007/s00198-009-1078-8. Epub 2009 Oct 8.
3
The effect of PTH(1-84) or strontium ranelate on bone formation markers in postmenopausal women with primary osteoporosis: results of a randomized, open-label clinical trial.甲状旁腺素(1-84)或雷奈酸锶对绝经后原发性骨质疏松症妇女骨形成标志物的影响：一项随机、开放标签临床试验的结果。
Osteoporos Int. 2011 Sep;22(9):2529-37. doi: 10.1007/s00198-010-1460-6. Epub 2010 Oct 30.
4
Effects of strontium ranelate, raloxifene and misoprostol on bone mineral density in ovariectomized rats.雷洛昔芬和米索前列醇对去卵巢大鼠骨密度的影响。
Eur J Obstet Gynecol Reprod Biol. 2009 Dec;147(2):192-4. doi: 10.1016/j.ejogrb.2009.09.001. Epub 2009 Sep 30.
5
[New bone density conservation agents for osteoporosis under research and development: Strontium ranelate].[正在研发的用于骨质疏松症的新型骨密度保护剂：雷奈酸锶]
Nihon Rinsho. 2007 Nov 28;65 Suppl 9:447-53.
6
Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.雷奈酸锶：一种通过双重作用模式重新平衡骨转换以促进骨形成的药物。
Curr Opin Rheumatol. 2006 Jun;18 Suppl 1:S11-5. doi: 10.1097/01.bor.0000229522.89546.7b.
7
[Strontium ranelate].[雷奈酸锶]
Clin Calcium. 2006 Jan;16(1):137-44.
8
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.锶雷尼酸通过对骨吸收和形成的相反作用来预防骨质疏松症。
Osteoporos Int. 2011 Jun;22(6):1659-67. doi: 10.1007/s00198-010-1369-0. Epub 2010 Sep 2.
9
The effect of prior bisphosphonate therapy on the subsequent BMD and bone turnover response to strontium ranelate.双膦酸盐治疗史对雷奈酸锶后续骨密度和骨转换反应的影响。
J Bone Miner Res. 2010 Mar;25(3):455-62. doi: 10.1359/jbmr.090821.
10
Strontium ranelate improves bone microarchitecture in osteoporosis.雷奈酸锶可改善骨质疏松症患者的骨微观结构。
Rheumatology (Oxford). 2009 Oct;48 Suppl 4:iv9-13. doi: 10.1093/rheumatology/kep274.

引用本文的文献

1
The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.双膦酸盐治疗史对雷奈酸锶治疗 2 年后后续疗效的影响。
Osteoporos Int. 2012 Jan;23(1):295-303. doi: 10.1007/s00198-011-1547-8. Epub 2011 Jan 28.
2
How strontium ranelate, via opposite effects on bone resorption and formation, prevents osteoporosis.锶雷尼酸通过对骨吸收和形成的相反作用来预防骨质疏松症。
Osteoporos Int. 2011 Jun;22(6):1659-67. doi: 10.1007/s00198-010-1369-0. Epub 2010 Sep 2.

本文引用的文献

1
Relationship between 3-month changes in biochemical markers of bone remodelling and changes in bone mineral density and fracture incidence in patients treated with strontium ranelate for 3 years.在使用雷奈酸锶治疗 3 年后，骨代谢生化标志物 3 个月变化与骨密度变化和骨折发生率的关系。
Osteoporos Int. 2010 Jun;21(6):1031-6. doi: 10.1007/s00198-009-1078-8. Epub 2009 Oct 8.
2
Effect of long-term treatment with strontium ranelate on bone strontium content.雷奈酸锶长期治疗对骨锶含量的影响。
Bone. 2009 Aug;45(2):200-6. doi: 10.1016/j.bone.2009.04.196. Epub 2009 Apr 17.
3
Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
特立帕肽与雷奈酸锶对绝经后骨质疏松症女性骨活检及骨转换生化标志物的比较效应
J Bone Miner Res. 2009 Aug;24(8):1358-68. doi: 10.1359/jbmr.090315.
4
Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.雷奈酸锶降低绝经后骨质疏松症女性非椎体骨折风险：外周骨质疏松症治疗（TROPOS）研究。
J Clin Endocrinol Metab. 2005 May;90(5):2816-22. doi: 10.1210/jc.2004-1774. Epub 2005 Feb 22.
5
The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis.雷奈酸锶对绝经后骨质疏松症女性椎体骨折风险的影响。
N Engl J Med. 2004 Jan 29;350(5):459-68. doi: 10.1056/NEJMoa022436.